Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialAlexandre Mebazaa, Gad Cotter, Beth A. Davison et al.|The Lancet|2022Cited by 1k
Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)Ferenc Folláth, Alexandre Mebazaa, Mehmet Birhan Yılmaz et al.|Intensive Care Medicine|2011Cited by 293
Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the WorldRavi V. Shah, Alexandre Mebazaa, Étienne Gayat et al.|Journal of the American College of Cardiology|2013Cited by 251
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) studyJohan Lassus, Alexandre Mebazaa, Étienne Gayat et al.|International Journal of Cardiology|2013Cited by 237
Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methodsAlexandre Mebazaa, Ferenc Folláth, John Parissis et al.|Intensive Care Medicine|2010Cited by 228